Bank of New York Mellon’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.49M Buy
612,658
+22,781
+4% +$204K ﹤0.01% 2209
2025
Q1
$4.42M Sell
589,877
-7,061
-1% -$53K ﹤0.01% 2278
2024
Q4
$4.49M Buy
596,938
+100
+0% +$752 ﹤0.01% 2340
2024
Q3
$4.54M Sell
596,838
-179,119
-23% -$1.36M ﹤0.01% 2332
2024
Q2
$4.8M Buy
775,957
+86,249
+13% +$533K ﹤0.01% 2366
2024
Q1
$3.5M Sell
689,708
-62,277
-8% -$316K ﹤0.01% 2490
2023
Q4
$4.5M Sell
751,985
-15,586
-2% -$93.4K ﹤0.01% 2423
2023
Q3
$5.43M Buy
767,571
+8,087
+1% +$57.3K ﹤0.01% 2270
2023
Q2
$5.35M Buy
759,484
+88,876
+13% +$626K ﹤0.01% 2292
2023
Q1
$5.59M Sell
670,608
-6,414
-0.9% -$53.5K ﹤0.01% 2239
2022
Q4
$7.77M Buy
677,022
+5,610
+0.8% +$64.4K ﹤0.01% 2073
2022
Q3
$8.46M Buy
671,412
+51,541
+8% +$649K ﹤0.01% 1995
2022
Q2
$6.56M Sell
619,871
-272,237
-31% -$2.88M ﹤0.01% 2170
2022
Q1
$14.5M Buy
892,108
+34,176
+4% +$556K ﹤0.01% 1865
2021
Q4
$11.9M Buy
857,932
+110,111
+15% +$1.52M ﹤0.01% 2009
2021
Q3
$10.7M Buy
747,821
+9,508
+1% +$137K ﹤0.01% 2079
2021
Q2
$11.7M Buy
738,313
+23,412
+3% +$370K ﹤0.01% 2040
2021
Q1
$7.27M Sell
714,901
-43,201
-6% -$439K ﹤0.01% 2263
2020
Q4
$5.65M Buy
758,102
+31,668
+4% +$236K ﹤0.01% 2304
2020
Q3
$2.5M Sell
726,434
-104,484
-13% -$359K ﹤0.01% 2537
2020
Q2
$3.96M Buy
830,918
+180,280
+28% +$859K ﹤0.01% 2328
2020
Q1
$1.3M Buy
650,638
+106,837
+20% +$214K ﹤0.01% 2788
2019
Q4
$1.88M Buy
543,801
+109,121
+25% +$376K ﹤0.01% 2850
2019
Q3
$1.25M Sell
434,680
-17,602
-4% -$50.5K ﹤0.01% 3037
2019
Q2
$1.71M Sell
452,282
-450,378
-50% -$1.71M ﹤0.01% 2880
2019
Q1
$7.35M Buy
902,660
+359,634
+66% +$2.93M ﹤0.01% 2133
2018
Q4
$4.38M Buy
543,026
+122,201
+29% +$986K ﹤0.01% 2376
2018
Q3
$3.21M Buy
420,825
+12,544
+3% +$95.7K ﹤0.01% 2605
2018
Q2
$2.34M Sell
408,281
-54,089
-12% -$310K ﹤0.01% 2767
2018
Q1
$2.21M Sell
462,370
-1,821
-0.4% -$8.68K ﹤0.01% 2750
2017
Q4
$2.28M Buy
464,191
+94,160
+25% +$462K ﹤0.01% 2767
2017
Q3
$1.94M Buy
370,031
+470
+0.1% +$2.46K ﹤0.01% 2857
2017
Q2
$2.06M Buy
369,561
+8,272
+2% +$46K ﹤0.01% 2833
2017
Q1
$3.04M Buy
361,289
+23,072
+7% +$194K ﹤0.01% 2598
2016
Q4
$2.14M Buy
338,217
+19,338
+6% +$122K ﹤0.01% 2807
2016
Q3
$1.41M Buy
318,879
+12,316
+4% +$54.3K ﹤0.01% 2986
2016
Q2
$870K Sell
306,563
-552
-0.2% -$1.57K ﹤0.01% 3238
2016
Q1
$869K Sell
307,115
-18,025
-6% -$51K ﹤0.01% 3146
2015
Q4
$3.36M Sell
325,140
-5,403
-2% -$55.8K ﹤0.01% 2411
2015
Q3
$3.77M Sell
330,543
-61,347
-16% -$699K ﹤0.01% 2393
2015
Q2
$5.85M Buy
391,890
+25,926
+7% +$387K ﹤0.01% 2259
2015
Q1
$3.3M Sell
365,964
-368
-0.1% -$3.32K ﹤0.01% 2541
2014
Q4
$4.45M Buy
366,332
+9,122
+3% +$111K ﹤0.01% 2365
2014
Q3
$3.49M Buy
357,210
+32,495
+10% +$318K ﹤0.01% 2523
2014
Q2
$4.14M Buy
324,715
+233,580
+256% +$2.98M ﹤0.01% 2425
2014
Q1
$964K Sell
91,135
-22,236
-20% -$235K ﹤0.01% 3299
2013
Q4
$862K Sell
113,371
-7,345
-6% -$55.8K ﹤0.01% 3364
2013
Q3
$878K Buy
120,716
+36,523
+43% +$266K ﹤0.01% 3306
2013
Q2
$131K Buy
+84,193
New +$131K ﹤0.01% 3848